¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary amino acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
¿µ¹® nucleic acid ÇÑ±Û ÇÙ»ê
¼³¸í   
  ¿°±â, ´ç, ÀλêÀ¸·Î ÀÌ·ç¾îÁø ´ºÅ¬·¹¿ÀƼµå°¡ ±ä »ç½½ ¸ð¾çÀ¸·Î ÁßÇյȠ°íºÐÀÚ ¹°Áú. À¯ÀüÀ̳ª ´Ü¹éÁú ÇÕ¼ºÀ» Áö¹èÇϴ Áß¿äÇÑ ¹°Áú·Î, »ý¹°ÀÇ Áõ½ÄÀ» ºñ·ÔÇÑ »ý¸í È°µ¿ À¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù. ±¸¼º ´çÀΠ¿Àź´çÀÌ ¸®º¸¿À½ºÀΠ¸®º¸ÇÙ»ê°ú µð¿Á½Ã¸®º¸¿À½ºÀΠµð¿Á½Ã¸®º¸ ÇÙ»êÀ¸·Î ³ª´¶´Ù. ÆæÅ佺·Î¼­ ¸®º¸½º³ª µ¥¿Á½Ã¸®º¸½º ¾î´À ÇÑÂʸ¸À» Æ÷ÇÔÇϸç ÀüÀÚ¸¦ ¸®º¸ÇÙ»ê(RNA), ÈÄÀÚ¸¦ µ¥¿Á½Ã¸®º¸ÇÙ»ê(deoxyribonucleic acid, DNA)À̶ó ºÎ¸¥´Ù. ¸ðµÎ 4Á¾·ùÀÇ À¯±â¿°±â¿¡ ÀÇÇØ Æ¯Â¡Áö¾îÁö¸ç ¾Æµ¥´Ñ, ±¸¾Æ´Ñ ¹× ½ÃÅä½ÅÀº ¾çÀÚ¿¡ °øÅëÀÌ´Ù. Æ¼¹ÎÀº DNA¿¡, ¿ì¶ó½ÇÀº RNA¿¡ Æ÷ÇԵȴÙ. DNA´Â ÁַΠÇÙ¿¡ Á¸ÀçÇϸç ÇüÁúÀ¯Àü¿¡ ±×¸®°í RNA´Â ¼¼Æ÷Áú¼Ó¿¡¼­ ´Ü¹éÁú ÇÕ¼º¿¡ °ü¿©ÇÑ´Ù. ¼·ÃëµÈ ÇÙ»êÀº ¼ÒÈ­°ü¿¡¼­ ±¸¼ººÐÀڷαîÁö °¡¼öºÐÇØµÇ¾î Èí¼öµÈ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary culture
    ÀÏÂ÷¹è¾ç, óÀ½½É±â
  • primary degenerative dementia
    ¿ø¹ßÅðÇàÄ¡¸Å
  • primary dentin
    ÀÏÂ÷»ó¾ÆÁú
  • primary dentition
    ÀÏÂ÷Ä¡¾Æ
  • primary depression
    ¿ø¹ß¿ì¿ïÁõ
  • primary dysmenorrhea
    ¿ø¹ß¿ù°æÅë
  • primary fissure
    ù°ƴ»õ, ¼Ò³úÁ¦ÀÏ¿­
  • primary focus
    ¿ø¹ßº´ÅÍ
  • primary follicle
    ÀÏÂ÷³­Æ÷
  • primary hair
    ÀÏÂ÷ÅÐ, ¹è³Á¼ØÅÐ
  • primary health care
    ÀÏÂ÷º¸°ÇÀÇ·á
  • primary host
    Á¾¼÷ÁÖ
  • primary hypertension
    ¿ø¹ß¼º°íÇ÷¾Ð
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • primary impression
    ÀÏÂ÷Àλó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mandelic acid
    ¸¸µ¨¸°»ê
  • methylhippuric acid
    ¸ÞÆ¿¸¶´¢»ê
  • nucleic acid
    ÇÙ»ê
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyruvic acid
    ÇÇ·çºê»ê
  • retinoic acid
    ·¹Æ¼³ë»ê, ·¹Æ¼³ëÀλê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • succinic acid
    ¼÷½Å»ê
  • sulfuric acid
    Ȳ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • valproic acid
    ¹ßÇÁ·ÎÀÌÅ©»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary ossification center
    ÀÏÂ÷»ÀµÇ±âÁß½É, ÀÏÂ÷°ñÈ­Áß½É
  • primary sex character
    ÀÏÂ÷¼ºÂ¡
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary dentin
    ÀÏÂ÷»ó¾ÆÁú
  • primary dentition
    (¢¡deciduous tooth) Á¥´Ï, Å»¶ôÄ¡¾Æ
  • primary depression
    ÀÏÂ÷¿ì¿ïÁõ
  • primary dysmenorrhea
    ¿ø¹ß¿ù°æÅë
  • primary ciliary dyskinesia
    ¿ø¹ß¼¶¸ð¿îµ¿ÀÌ»óÁõ
  • primary degenerative dementia
    ÀÏÂ÷ÅðÇàÄ¡¸Å
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • primary epilepsy
    ¿ø¹ß°£Áú, ÀÏÂ÷°£Áú
  • primary fissure
    ù°ƴ»õ
  • primary focus
    ¿øº´ÅÍ
  • primary follicle
    ÀÏÂ÷³­Æ÷
  • primary hair
    (¢¡lanugo) ¹è³Á¼ØÅÐ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Deoxycholic acid
    µð¿Á½ÃÄݸ¯»ê
  • Deoxyribonucleic acid
    µð¿Á½Ã¸®º¸´ºÅ¬·¹ÀÍ»ê
  • FA fatty acid
    Áö¹æ»ê.
  • FFA= free fatty acid
    À¯¸®Áö¹æ»ê.
  • Fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • Fatty acid-CoA
    Áö¹æ»ê(ò·Û¸ß«) ÄÚ¿£ÀÚÀÓA
  • Folic acid
    ¿±»ê(ç¨ß«)
  • GABA=> gamma aminobutyric acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê.
  • GABA=£¾gamma aminobutylic acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê.
  • GABA=£¾gamma aminobutylic acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê(ß«).
  • Gamma-aminobutyric acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê(ß«)
  • Glycogen-lactic acid system
    ±Û¸®ÄÚ°Õ-¶ôÆ®»ê°è
  • Growth folic acid in
    ¼ºÀå(à÷íþ)¿°»ê(ç¤ß«)¿°
  • HIAA = 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·ÎÀε¹ÃÊ»ê
  • Hydrochloric acid
    ÇÏÀ̵å·ÎÅ©·Ð»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acetic anhydride-acetic acid-sulfuric acid
    ¹«¼öÃÊ»ê-ÃÊ»ê-Ȳ»ê
  • acid-base balance=acid-base equilibrium
    »ê¿°±â ÆòÇü(¡­øÁû¬)
  • hydroxyindoleacetic acid, 5-hydroxyindoleacetic acid (5-hiaa)
    5-ÇÏÀ̵å·Ï½ÃÀε¹¾Æ¼¼Æ®»ê
  • amyloidosis primary
    ¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • carcinoma, primary bronchogenic
    ¿ø¹ß¼º±â°üÁö¿ø¼º¾ÏÁ¾
  • culture, primary
    ÀÏÂ÷¹è¾ç
  • diploid primary gametocyte
    µÎ¹è¼öüÀÏÂ÷»ý½Ä¼¼Æ÷
  • idopathic primary pulmonary hemaosiderosis
  • immune response, primary
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • immunodeficiency syndrome, primary
    ÀÏÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • infection, primary
    ÀÏÂ÷°¨¿°
  • interaction, primary
    ÀÏÂ÷»óÈ£ÀÛ¿ë
  • occult primary tumor
    Àẹ¿ø¹ßÁ¾¾ç
  • persistent hyperplastic primary vitreous
  • pneumonia, primary atypical
    ¿ø¹ß¼º ºñÁ¤ÇüÆó·Å
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Primary nodule
    ÀÏÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÏÂ÷¼ÒÀý
  • Primary bud
    ÀÏÂ÷½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷·Ú
  • Primary amnion
    ÀÏÂ÷¾ç¸·
    [¿¾ ¿ë¾î] ÀÏÂ÷¾ç¸·
  • Primary villus
    ÀÏÂ÷À¶¸ð
    [¿¾ ¿ë¾î] ÀÏÂ÷À¶¸ð
  • Primary pregnancy
    ÀÏÂ÷ÀÓ½Å
    [¿¾ ¿ë¾î] ÀÏÂ÷ÀÓ½Å
  • Primary spermatocyte
    ÀÏÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷Á¤¸ð¼¼Æ÷
  • Primary spermatocyte
    ÀÏÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] Á¦ÀÏÁ¤¸ð¼¼Æ÷
  • Primary nasal septum
    ÀÏÂ÷ÄÚÁß°Ý
    [¿¾ ¿ë¾î] ÀÏÂ÷ºñÁß°Ý
  • Primary hair follicle
    ÀÏÂ÷ÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷¸ð³¶
  • Primary sponge bone
    ÀÏÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÏÂ÷ÇØ¸é°ñ
  • Primary pulmonary lobule
    ÀÏÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÏÂ÷Æó¼Ò¿±
  • Primary septum
    ù°»çÀ̸·
    [¿¾ ¿ë¾î] Á¦ÀÏÁß°Ý
  • Primary fissure
    ù°ƴ»õ
    [¿¾ ¿ë¾î] Á¦1·Ä
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • conservative amino acid replacement
    "º¸Á¸¼º(ÜÁðíàõ) ¾Æ¹Ì³ë»ê ´ëÄ¡(ÓÛöÇ), (ÔÒ) conservative substitution"
  • dansyl amino acid
    ´í½Ç ¾Æ¹Ì³ë»ê(ß«)
  • dinitrophenyl amino acid
    ÀÌ(ì£)´ÏÆ®·ÎÆä´Ò ¾Æ¹Ì³ë»ê(ß«)
  • dispensable amino acid
    "ºñÇʼö(Þªù±âÎ) ¾Æ¹Ì³ë»ê(ß«), °¡°á(ʦÌÀ)¾Æ¹Ì³ë»ê(ß«), (ÔÒ) nonessential amino acid"
  • DNP-amino acid
    DNP-¾Æ¹Ì³ë»ê(ß«) (ÔÒ) dinitrophenyl amino acid
  • Dns-amino acid
    Dns-¾Æ¹Ì³ë»ê(ß«) (ÔÒ) dansyl amino acid
  • essential amino acid
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«)
  • essential amino acid index
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«) Áö¼ö(ò¦â¦)
  • glucoplastic amino acid
    ±Û·çÄÚ½º»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • glycogenic amino acid
    ±Û¶óÀÌÄÚÀü »ý¼º(ßæà÷)¾Æ¹Ì³ë»ê(ß«)
  • helix-breaking amino acid
    ³ª¼±(Õ¢àÁ) ±ú±â ¾Æ¹Ì³ë»ê(ß«)
  • homocodonic amino acid
    ±Õ(г)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
  • indispensable amino acid
    ºÒ°¡°á(ÝÕʦÌÀ) ¾Æ¹Ì³ë»ê(ß«)
  • ketogenic amino acid
    ÄÉÅæ»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • limiting amino acid
    Á¦ÇÑ(ð¤ùÚ)¾Æ¹Ì³ë»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PAH   1) Para(p)-Amino-Hippurate
  2) Primary Alveolar Hyperventilation
OA obstructive apnea; occipital artery; occipito-anterior; occiput anterior; octanoic acid; ocular albi...
PAA partial agonist activity; phenylacetic acid; phosphonoacetic acid; physical abilities analysis; plas...
PAP pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa...
PCCM pediatric critical care medicine; primary care case management; primary care case manager
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AIB 2-amino isobutyric acid
2APV 2-amino-phosphono valeric acid
AP-5 D(-)-2-Amino-5-phosphonopentanoic acid
-]APH 2-amino-7-phosphonoheptanoic acid
3 APS 3 amino propane sulphonic acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary afferent projection
    ÀÏÂ÷ ±¸½É¼º Åõ»ç
  • primary afferent terminal
    ÀÏÂ÷ ±¸½É¼º ¸»´Ü
  • primary amenorrhea
    ¿ø¹ß ¹«¿ù°æ, ¿ø¹ß¼º ¹«¿ù°æ
  • primary amyloidosis
    ¿ø¹ß¼º À¯ÀüºÐÁõ, ¿ø¹ß ¾Æ¹Ð·ÎÀ̵åÁõ, ¿ø¹ß¼º ¾Æ¹Ð·ÎÀ̵åÁõ
  • primary anesthesia
    ÀÏÂ÷ ¸¶Ãë
  • primary benign leukoplakias
    ¿ø¹ß¼º ¾ç¼º ¹é¹ÝÁõ
  • primary bond
    ÀÏÂ÷ °áÇÕ
    ÀϹÝÀûÀ¸·Î À̿ °áÇÕ, °øÀ¯ °áÇÕ, ¹èÀ§ °áÇÕ, ±Ý¼Ó °áÇÕ µîÀ» ¸»ÇÏ¸ç °áÇÕ·ÂÀÌ °¡Àå °­ÇÏ´Ù
  • primary bullous dermatoses
    ¿ø¹ß ¼öÆ÷¼º ÇǺκ´
  • primary carcinoma
    ¿ø¹ß ¾ÏÁ¾
  • primary cement
    ÀÏÂ÷ ½Ã¸àÆ®Áú, Á¦ÀÏ ½Ã¸àÆ®Áú
  • primary cephalic vein
    ÀÏÂ÷ ¸Ó¸® Á¤¸Æ
  • primary closure
    ÀÏÂ÷ ºÀÇÕ
  • primary color
    ¿ø»ö, ±âº»»ö
    µ¿ÀǾî=fundamental color. È¥ÇÕ¿¡ ÀÇÇØ¼­ ´Ù¸¥ »ö±òÀ» ¸¸µå´Âµ¥ ÀÌ¿ëµÇ´Â 3°¡Áö ±âº»»öÀ¸·Î ºûÀÇ ºÎ°¡ÀûÀΠȥÇÕÀ̳ª Âø»öÁ¦¸¦ »« °ÍÀÌ´Ù.
  • primary colors subtractive
    °¨»ö
  • primary culture
    Ãʹè¾ç, ÃÊ´ë ¹è¾ç, ÀÏÂ÷ ¹è¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
sequence homology, amino acid The degree of similarity between sequences of amino acids. This information is useful for the understanding of genetic relatedness of certain species.
(12 Dec 1998)
N-(5-amino-1-ribosyl-4-imidazolylcarbonyl)-L-aspartic acid 5'-phosphate synthetase <enzyme> 5-amino-1-ribosyl-4-imidazole carboxylic acid 5'-phosphate (carboxy-air), ATP and aspartate yield n(5-amino-4-imidazolylcarbonyl)-l-aspartic acid 5'-phosphate(succino-aicar), ADP and p
Registry number: EC 6.3.4.-
(26 Jun 1999)
N(6)-(6-carbamoylhexyl)-FAD-D-amino acid oxidase <enzyme> A semi-synthetic oxidase; prepared by reacting the succinimido ester of n(6)-(6-carboxyhexyl)-fad with apo-d-amino acid oxidase from pig kidney in the presence of the benzoate
Registry number: EC 1.4.3.-
Synonym: nch-fad-daao
(26 Jun 1999)
N-carbamoyl-D-amino acid amidohydrolase <enzyme> From comamonas sp.e222c; mw 120 kD; hydrolyzes d-enantiomers of various n-carbamoyl-d-amino acids to d-amino acids, ammonia and co2; sensitive to thiol reagents; does not require metal ions
Registry number: EC 3.5.1.-
Synonym: caa-amidohydrolase, carbamoyl d-aa amidohyrolase
(26 Jun 1999)
nonessential amino acid <biochemistry> The amino acid's that can be synthesised by an organism and are thus not required in the diet.
(05 Mar 2000)
nonpolar amino acid An alpha-amino acid in which the functional group attached to the alpha-carbon (i.e., R in RCH(NH2)COOH) has hydrophobic properties; e.g., valine, leucine, alpha-aminobutyrate.
(05 Mar 2000)
D-amino acid malonyltransferase <enzyme> From mung beans
Registry number: EC 2.3.1.-
Synonym: 1-aminocyclopropanecarboxylate malonyltransferase, d-acc-malonyltransferase, acc n-malonyltransferase
(26 Jun 1999)
d-amino-acid oxidase <enzyme> Chemical name: D-Amino-acid:oxygen oxidoreductase (deaminating)
Registry number: EC 1.4.3.3
(12 Dec 1998)
D-amino acid transaminase <enzyme> Catalyses the alpha,beta elimination of the (d)-isomer of beta-chloroalanine or other amino acids to yield pyruvate, chloride and ammonia
Registry number: EC 2.6.1.-
(26 Jun 1999)
D-amino acid transferase <enzyme> Mw 41 kD; catalyses d-amino acid transfer; d-configuration specific; recognises aromatic d-amino acid esters to form oligo d-amino acid esters
Registry number: EC 2.3.2.-
(26 Jun 1999)
dibasic amino acid An amino acid containing a second basic group (usually an amino group); e.g., lysine, arginine, ornithine.
Synonym: dibasic amino acid.
(05 Mar 2000)
essential amino acid <biochemistry> Those amino acids that cannot be synthesised by an organism and must therefore be present in the diet. The term is often applied anthropocentrically to those amino acids required by humans (Ileu, Leu, Lys, Met, Phe, Thr, Try, & Val), though rats need two more (Arg & His).
(18 Nov 1997)
excitatory amino acid <biochemistry> The naturally occurring amino acids L glutamate and L aspartate and their synthetic analogues, notably kainate, quisqualate and NMDA. They have the properties of excitatory neurotransmitters in the CNS, may be involved in long-term potentiation and can act as excitotoxins.
at least three classes of EAA receptor have been identified, the agonists of the N type receptor are L aspartate, NMDA and ibotenate, the agonists of the Q type receptor are L glutamate and quisqualate, agonists of the K type are L glutamate and kainate. All three receptor types are found widely in the CNS and particularly the telencephalon, N and Q type receptors tend to occur together and may interact, their distribution is complementary to the K type receptors. The ion fluxes through the Q and K receptors are relatively brief, whereas the flux through the N type is longer and carries a significant amount of calcium. Additionally the N type receptor is blockaded by magnesium near the resting potential and thus shows voltage gated ion channel properties, leading to a regenerative response, this is why N type receptors have been linked to long-term potentiation.
Invertebrate glutamate receptors may not have the same properties as those described above.
(18 Nov 1997)
excitatory amino acid agents Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.
(12 Dec 1998)
excitatory amino acid agonists Drugs that bind to and activate excitatory amino acid receptors.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary structure
    ÃÊ¿øÀû ±¸Á¶¹°(ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦À۵Ǵ ÀüÀ§ Á¶°¢)
  • primary tenses
    (¶óƾ,±×¸®½º¾îÀÇ) Á¦ 1½ÃÁ¦(ÇöÀç,¹Ì·¡,°ú°Å ¶Ç´Â ¿Ï·áÀÇ ÃÑĪ)
  • primary wall
    (¼¼Æ÷¸·ÀÇ) 1Â÷¸·
  • runoff primary
    °á¼± ÅõÇ¥(µÎ ÃÖ°í µæÇ¥ÀÚÁß Áö¸í È帰¡ µÉ »ç¶÷À» Á¤ÇÏ´Â)
  • white primary
    ¹éÀÎ ¿¹¼±È¸(¹Ì±¹ ³²ºÎ ¿©·¯ ÁÖÀÇ ¹éÀθ¸ÀÌ ÅõÇ¥ÇÏ´ø ¹ÎÁÖ´çÀÇ ¿¹ºñ ¼±°Å)
  • acid
    ½Å
  • citric acid
    ±¸¿¬»ê
  • acetic acid
    ÃÊ»ê
  • acetylsalicylic acid
    =ASPIRIN
  • acid
    »ê;½Å¸À(ÀÌ ÀÖ´Â);½Å;½Å¶öÇÑ;ºÎ·çÅüÇÑ
  • acid test
    »ê½ÃÇè;¾ö¹ÐÇѽÃÇè
  • acid trip
    LSD¿¡ÀÇÇÑ È¯°¢Ã¼Çè
  • acrylic acid
    ¾ÆÅ©¸±»ê
  • aminobenzoic acid
    ¾Æ¹Ì³ë¾È½ÄÇâ»ê
  • arsenious acid
    ¾Æºñ»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á